Position in MRK
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$751,596
+$212,818 QoQ
Shares Held
5,849
+30.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.68%
of 13F equity value
Holder Rank
#2,354
of 3,769 holders
Holding Since
Jun 2023
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Providence First Trust Co holds $5,635,150 across 8 Drug Manufacturers - General names. MRK ranks #4 (13.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,058 | $1,268,997 | |
| 2 | JNJ |
Johnson & Johnson
|
3,806 | $966,609 | |
| 3 | BIIB |
Biogen Inc.
|
4,175 | $902,050 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
5,849 | $751,596 | |
| 5 | AZN |
Astrazeneca PLC
|
3,092 | $586,305 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,775 | $476,933 | |
| 7 | AMGN |
Amgen Inc
|
979 | $354,515 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,695 | $328,145 |
All Filings in MRK
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $751,596 | 5,849 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $538,778 | 4,479 | Shares | Sole | 2026-05-05 | |
| 2024-12-31 | $13,429 | 135 | Shares | Sole | 2025-02-05 | |
| 2023-12-31 | $733,159 | 6,725 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $692,338 | 6,725 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $1,020,624 | 8,845 | Shares | Sole | 2023-08-09 | |
| No filing history on record for this holder in this stock. | ||||||